Correction: Flavagline analog FL3 induces cell cycle arrest in urothelial carcinoma cell of the bladder by inhibiting the Akt/PHB interaction to activate the GADD45α pathway (Journal of Experimental & Clinical Cancer Research, (2018), 37, 1, (21), 10.1186/s13046-018-0695-5)

Gangjun Yuan; Xin Chen; Zhuowei Liu; Wensu Wei; Qinghai Shu; Hussein Abou-Hamdan; Lijuan Jiang; Xiangdong Li; Rixin Chen; Laurent Désaubry; Fangjian Zhou; Dan Xie

doi:10.1186/s13046-022-02502-2

Correction: Flavagline analog FL3 induces cell cycle arrest in urothelial carcinoma cell of the bladder by inhibiting the Akt/PHB interaction to activate the GADD45α pathway (Journal of Experimental & Clinical Cancer Research, (2018), 37, 1, (21), 10.1186/s13046-018-0695-5)

Gangjun Yuan
, Xin Chen
, Zhuowei Liu
, Wensu Wei
, Qinghai Shu
, Hussein Abou-Hamdan
, Lijuan Jiang
, Xiangdong Li
, Rixin Chen
, Laurent Désaubry^*
, Fangjian Zhou^*
, Dan Xie^*

^*Corresponding author for this work

School of Material Science and Engineering

Research output: Contribution to journal › Comment/debate

Abstract

Following publication of the original article [1], an error was identified in the image of PHB Control and Paclitaxel (10 mg/kg) in Fig. 5d. The correction does not have any effect on the results or conclusions of the paper. The original article has been corrected.

Original language	English
Article number	291
Journal	Journal of Experimental and Clinical Cancer Research
Volume	41
Issue number	1
DOIs	https://doi.org/10.1186/s13046-022-02502-2
Publication status	Published - Dec 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1186/s13046-022-02502-2

Fingerprint

Dive into the research topics of 'Correction: Flavagline analog FL3 induces cell cycle arrest in urothelial carcinoma cell of the bladder by inhibiting the Akt/PHB interaction to activate the GADD45α pathway (Journal of Experimental & Clinical Cancer Research, (2018), 37, 1, (21), 10.1186/s13046-018-0695-5)'. Together they form a unique fingerprint.

Cite this

Yuan, G., Chen, X., Liu, Z., Wei, W., Shu, Q., Abou-Hamdan, H., Jiang, L., Li, X., Chen, R., Désaubry, L., Zhou, F., & Xie, D. (2022). Correction: Flavagline analog FL3 induces cell cycle arrest in urothelial carcinoma cell of the bladder by inhibiting the Akt/PHB interaction to activate the GADD45α pathway (Journal of Experimental & Clinical Cancer Research, (2018), 37, 1, (21), 10.1186/s13046-018-0695-5). Journal of Experimental and Clinical Cancer Research, 41(1), Article 291. https://doi.org/10.1186/s13046-022-02502-2

Yuan, Gangjun ; Chen, Xin ; Liu, Zhuowei et al. / Correction : Flavagline analog FL3 induces cell cycle arrest in urothelial carcinoma cell of the bladder by inhibiting the Akt/PHB interaction to activate the GADD45α pathway (Journal of Experimental & Clinical Cancer Research, (2018), 37, 1, (21), 10.1186/s13046-018-0695-5). In: Journal of Experimental and Clinical Cancer Research. 2022 ; Vol. 41, No. 1.

@article{3142c50722c842f9a8ae396227aef73b,

title = "Correction: Flavagline analog FL3 induces cell cycle arrest in urothelial carcinoma cell of the bladder by inhibiting the Akt/PHB interaction to activate the GADD45α pathway (Journal of Experimental \& Clinical Cancer Research, (2018), 37, 1, (21), 10.1186/s13046-018-0695-5)",

abstract = "Following publication of the original article [1], an error was identified in the image of PHB Control and Paclitaxel (10 mg/kg) in Fig. 5d. The correction does not have any effect on the results or conclusions of the paper. The original article has been corrected.",

author = "Gangjun Yuan and Xin Chen and Zhuowei Liu and Wensu Wei and Qinghai Shu and Hussein Abou-Hamdan and Lijuan Jiang and Xiangdong Li and Rixin Chen and Laurent D{\'e}saubry and Fangjian Zhou and Dan Xie",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2022.",

year = "2022",

month = dec,

doi = "10.1186/s13046-022-02502-2",

language = "English",

volume = "41",

journal = "Journal of Experimental and Clinical Cancer Research",

issn = "0392-9078",

publisher = "BioMed Central Ltd.",

number = "1",

}

Yuan, G, Chen, X, Liu, Z, Wei, W, Shu, Q, Abou-Hamdan, H, Jiang, L, Li, X, Chen, R, Désaubry, L, Zhou, F & Xie, D 2022, 'Correction: Flavagline analog FL3 induces cell cycle arrest in urothelial carcinoma cell of the bladder by inhibiting the Akt/PHB interaction to activate the GADD45α pathway (Journal of Experimental & Clinical Cancer Research, (2018), 37, 1, (21), 10.1186/s13046-018-0695-5)', Journal of Experimental and Clinical Cancer Research, vol. 41, no. 1, 291. https://doi.org/10.1186/s13046-022-02502-2

Correction: Flavagline analog FL3 induces cell cycle arrest in urothelial carcinoma cell of the bladder by inhibiting the Akt/PHB interaction to activate the GADD45α pathway (Journal of Experimental & Clinical Cancer Research, (2018), 37, 1, (21), 10.1186/s13046-018-0695-5). / Yuan, Gangjun; Chen, Xin; Liu, Zhuowei et al.
In: Journal of Experimental and Clinical Cancer Research, Vol. 41, No. 1, 291, 12.2022.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction

T2 - Flavagline analog FL3 induces cell cycle arrest in urothelial carcinoma cell of the bladder by inhibiting the Akt/PHB interaction to activate the GADD45α pathway (Journal of Experimental & Clinical Cancer Research, (2018), 37, 1, (21), 10.1186/s13046-018-0695-5)

AU - Yuan, Gangjun

AU - Chen, Xin

AU - Liu, Zhuowei

AU - Wei, Wensu

AU - Shu, Qinghai

AU - Abou-Hamdan, Hussein

AU - Jiang, Lijuan

AU - Li, Xiangdong

AU - Chen, Rixin

AU - Désaubry, Laurent

AU - Zhou, Fangjian

AU - Xie, Dan

PY - 2022/12

Y1 - 2022/12

N2 - Following publication of the original article [1], an error was identified in the image of PHB Control and Paclitaxel (10 mg/kg) in Fig. 5d. The correction does not have any effect on the results or conclusions of the paper. The original article has been corrected.

AB - Following publication of the original article [1], an error was identified in the image of PHB Control and Paclitaxel (10 mg/kg) in Fig. 5d. The correction does not have any effect on the results or conclusions of the paper. The original article has been corrected.

UR - https://www.scopus.com/pages/publications/85139187944

U2 - 10.1186/s13046-022-02502-2

DO - 10.1186/s13046-022-02502-2

M3 - Comment/debate

C2 - 36180869

AN - SCOPUS:85139187944

SN - 0392-9078

VL - 41

JO - Journal of Experimental and Clinical Cancer Research

JF - Journal of Experimental and Clinical Cancer Research

IS - 1

M1 - 291

ER -

Yuan G, Chen X, Liu Z, Wei W, Shu Q, Abou-Hamdan H et al. Correction: Flavagline analog FL3 induces cell cycle arrest in urothelial carcinoma cell of the bladder by inhibiting the Akt/PHB interaction to activate the GADD45α pathway (Journal of Experimental & Clinical Cancer Research, (2018), 37, 1, (21), 10.1186/s13046-018-0695-5). Journal of Experimental and Clinical Cancer Research. 2022 Dec;41(1):291. doi: 10.1186/s13046-022-02502-2

Correction: Flavagline analog FL3 induces cell cycle arrest in urothelial carcinoma cell of the bladder by inhibiting the Akt/PHB interaction to activate the GADD45α pathway (Journal of Experimental & Clinical Cancer Research, (2018), 37, 1, (21), 10.1186/s13046-018-0695-5)

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this